RITUXIMAB AND HYALURONIDASE

453 reported adverse events

Drug classes: CD20-directed Cytolytic Antibody [EPC] Endoglycosidase [EPC]

These side effects are most commonly reported by patients taking RITUXIMAB AND HYALURONIDASE:

# Side effect Count
0 NO ADVERSE EVENT 88
1 OFF LABEL USE 82
2 RASH 50
3 FATIGUE 36
4 NAUSEA 35
5 PAIN 33
6 HEADACHE 28
7 DIZZINESS 27
8 PNEUMONIA 27
9 DYSPNOEA 26
See all common reactions for RITUXIMAB AND HYALURONIDASE

RITUXIMAB AND HYALURONIDASE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GRIP STRENGTH 13 0.0568
1 SWOLLEN JOINT COUNT 12 0.0480
2 MEDICAL AID IN DYING 1 0.0417
3 PARANEOPLASTIC RASH 1 0.0357
4 FOLLICULAR LYMPHOMA STAGE IV 1 0.0244
5 INFUSION SITE EXFOLIATION 1 0.0192
6 BASOPHILIA 1 0.0133
7 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 12 0.0127
8 ROSAI-DORFMAN SYNDROME 1 0.0127
9 PORPHYRIA ACUTE 17 0.0118
See all enriched reactions for RITUXIMAB AND HYALURONIDASE